Credit Suisse’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Credit Suisse’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,704	Closed	-$1.04M	–	3671
2021 Q1	$1.04M	Sell	20,704 -14,629	-41%	-$736K	﹤0.01%	2550
2020 Q4	$1.84M	Buy	35,333 +10,730	+44%	+$558K	﹤0.01%	2183
2020 Q3	$1.07M	Sell	24,603 -3,104	-11%	-$135K	﹤0.01%	2216
2020 Q2	$1.19M	Buy	+27,707	New	+$1.19M	﹤0.01%	2209
2020 Q1	–	Sell	-1,236,914	Closed	-$56.5M	–	3519
2019 Q4	$56.5M	Sell	1,236,914 -378,791	-23%	-$17.3M	0.04%	366
2019 Q3	$57.5M	Buy	1,615,705 +442,105	+38%	+$15.7M	0.05%	314
2019 Q2	$46.7M	Sell	1,173,600 -118,172	-9%	-$4.71M	0.04%	362
2019 Q1	$53.7M	Buy	+1,291,772	New	+$53.7M	0.05%	312
2018 Q4	–	Sell	-4,598	Closed	-$223K	–	3416
2018 Q3	$223K	Buy	+4,598	New	+$223K	﹤0.01%	3149
2017 Q4	–	Sell	-35,520	Closed	-$1.51M	–	3644
2017 Q3	$1.51M	Hold	35,520	–	–	﹤0.01%	2358
2017 Q2	$1.53M	Sell	35,520 -736	-2%	-$31.7K	﹤0.01%	2065
2017 Q1	$1.52M	Buy	36,256 +15,891	+78%	+$665K	﹤0.01%	2231
2016 Q4	$796K	Sell	20,365 -15,394	-43%	-$602K	﹤0.01%	2843
2016 Q3	$1.58M	Buy	+35,759	New	+$1.58M	﹤0.01%	2266
2016 Q2	–	Sell	-10,904	Closed	-$439K	–	3952
2016 Q1	$439K	Sell	10,904 -77,271	-88%	-$3.11M	﹤0.01%	3028
2015 Q4	$4.52M	Sell	88,175 -33,391	-27%	-$1.71M	0.01%	1534
2015 Q3	$5.7M	Buy	121,566 +10,384	+9%	+$487K	0.01%	1375
2015 Q2	$6.93M	Sell	111,182 -48,856	-31%	-$3.05M	0.01%	1346
2015 Q1	$9.88M	Buy	160,038 +69,026	+76%	+$4.26M	0.01%	1081
2014 Q4	$4.91M	Buy	91,012 +44,488	+96%	+$2.4M	﹤0.01%	1527
2014 Q3	$2.47M	Buy	+46,524	New	+$2.47M	﹤0.01%	2014
2014 Q2	–	Sell	-58,642	Closed	-$2.75M	–	4323
2014 Q1	$2.75M	Buy	58,642 +1,580	+3%	+$74K	﹤0.01%	1989
2013 Q4	$2.51M	Buy	57,062 +44,142	+342%	+$1.94M	﹤0.01%	2119
2013 Q3	$497K	Sell	12,920 -524,852	-98%	-$20.2M	﹤0.01%	3083
2013 Q2	$19M	Buy	+537,772	New	+$19M	0.02%	668